Akademska digitalna zbirka SLovenije - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov konzorcija SI. Za polni dostop se PRIJAVITE.

14 15 16
zadetkov: 155
151.
  • De novo AML patients with f... De novo AML patients with favourable–intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened “GO question”
    Clavio, Marino; Cruciani, Fabio; Minetto, Paola ... Annals of hematology, 10/2013, Letnik: 92, Številka: 10
    Journal Article
    Recenzirano

    We report the final results of a prospective trial testing the combination of fludarabine, Ara-C and idarubicin (FLAI) followed by low-dose gemtuzumab ozogamicin (FLAI-GO) in 85 patients aged ...
Celotno besedilo
Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ
152.
  • OpenFHE OpenFHE
    Al Badawi, Ahmad; Bates, Jack; Bergamaschi, Flavio ... Proceedings of the 10th Workshop on Encrypted Computing & Applied Homomorphic Cryptography, 11/2022
    Conference Proceeding

    Fully Homomorphic Encryption (FHE) is a powerful cryptographic primitive that enables performing computations over encrypted data without having access to the secret key. We introduce OpenFHE, a new ...
Celotno besedilo
Dostopno za: NUK, UL
153.
Celotno besedilo

PDF
154.
  • Longitudinal modeling of MS patient trajectories improves predictions of disability progression
    De Brouwer, Edward; Becker, Thijs; Moreau, Yves ... arXiv.org, 11/2020
    Paper, Journal Article
    Odprti dostop

    Research in Multiple Sclerosis (MS) has recently focused on extracting knowledge from real-world clinical data sources. This type of data is more abundant than data produced during clinical trials ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
155.
Celotno besedilo

PDF

Nalaganje filtrov